Clover Health Investments Crop. ($CLOV) Stock Forecast: Down 6.5% Today

What is Clover Health Investments Crop.?

Clover Health (CLOV) is a healthcare technology company specializing in offering Medicare Advantage plans to seniors. The company utilizes data-driven insights to enhance healthcare outcomes for its members.

Why is Clover Health Investments Crop. going down?

CLOV stock is down 6.5% on Mar 24, 2026 14:01

• Today's bearish movement in Clover Health's stock (CLOV) could be linked to a series of insider selling activities by top executives, such as CEO Jamie L. Reynoso and General Counsel Karen Soares. This may be perceived by the market as a lack of confidence in the company's future performance, resulting in a negative investor sentiment.
• Executives' automatic withholding of shares to cover tax obligations from RSU vesting might suggest potential cash flow issues or personal financial commitments, which could further affect investor confidence in the stock.
• In summary, insider selling paired with tax-related share withholding likely contributed to the stock's bearish performance today, as investors react to signs of potential internal issues within the company.

CLOV Price Chart

CLOV Technical Analysis

CLOV News

Clover Health (CLOV) Medicare Advantage CEO sells 5,833 shares in planned trade

Clover Health Investments' CEO of Medicare Advantage, Jamie L. Reynoso, sold 5,833 shares of Class A common stock in an open-market transaction at a weighted average price of $1.91 per share. This sale was executed on March 18, 2026, as part of a pre-arranged Rule 10b5-1 trading plan adopted on March 13, 2025. Following this transaction, Reynoso directly holds 2,716,735 Class A shares.

https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-f1e2be0e2434.html

RSU vesting triggers tax share withholding at Clover Health (CLOV)

Clover Health Investments' General Counsel, Karen Soares, had 4,528 shares of Class A common stock withheld to cover tax obligations. This occurred on March 15, 2026, when 6.25% of her September 15, 2022, time-based RSU grant vested. After the withholding, Soares directly held 1,200,061 shares of Class A common stock.

https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-26a4cb5cd9ce.html

Clover Health (CLOV) CEO has shares withheld to cover RSU taxes

Clover Health Investments, Corp.'s CEO of Counterpart Health, Conrad Wai, had 100,195 shares of Class A Common Stock automatically withheld on March 14, 2026, to cover tax obligations. This action was due to the vesting of the final portion of his time-based Restricted Stock Units (RSUs) granted in 2022. Following this, Wai directly holds 925,611 shares, with an additional 1,610,482 shares held indirectly in a family trust.

https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-1a1887991205.html

Clover Health (CLOV) exec Reynoso has shares withheld to cover RSU tax obligations

Clover Health Investments executive Jamie L. Reynoso had shares automatically withheld on March 14 and 15, 2026, to cover tax obligations arising from vested restricted stock units (RSUs). A total of 15,132 Class A Common shares were withheld at $1.98 per share, which were tax-withholding dispositions rather than open-market sales. Following these transactions, Reynoso directly holds 2,722,568 Class A shares.

https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-e167703e9b3a.html

Trending Today

Silver ($XAG) Commodity Forecast: Up 9.9% Today

Heating Oil ($HEATOIL) Commodity Forecast: Down 5.4% Today

Brent Crude Oil ($BRENT) Commodity Forecast: Down 5.1% Today

Gold ($XAU) Commodity Forecast: Up 5.1% Today

NASDAQ-100 ($NDX) Index Forecast: Up 0.3% Today

Kohl's Corporation ($KSS) Stock Forecast: Down 5.3% Today

Bumble Inc. ($BMBL) Stock Forecast: Down 5.0% Today

fuboTV Inc. ($FUBO) Stock Forecast: Up 1015.7% Today

Gartner Inc. ($IT) Stock Forecast: Down 7.3% Today

Albemarle Corporation ($ALB) Stock Forecast: Up 5.2% Today

Clover Health Investments Crop. Price History

18.02.2026 - CLOV Stock was down 5.1%

• Executives at Clover Health, including Jamie L. Reynoso and Conrad Wai, had shares withheld to cover tax obligations related to vested restricted stock units (RSUs).
• The automatic withholding of shares for tax purposes may have led to increased selling pressure on the stock, contributing to the bearish movement.
• Investors might interpret the executives' actions as a lack of confidence in the company's future performance, further dampening market sentiment towards Clover Health.
• The series of tax-related share withholdings could have signaled potential concerns about the company's financial health or regulatory challenges, prompting investors to react bearishly.

23.09.2025 - CLOV Stock was up 5.5%

• Participation in a global healthcare conference suggests potential positive developments or strategic partnerships for Clover Health.
• Investors may interpret the conference participation as a signal of industry recognition and future growth prospects for the company.
• The rise in CLOV's stock price could be linked to increased investor confidence after the announcement of the CFO's presentation at the conference.
• Market participants could be expecting favorable insights or announcements during the conference, leading to a surge in CLOV's stock price.

05.10.2025 - CLOV Stock was down 27.8%

• The bearish movement in CLOV could be attributed to the disappointing earnings report for Q3, with the company reporting break-even earnings and missing revenue expectations.
• Investors might be concerned about the company's future growth prospects, as indicated by the negative earnings surprise.
• The market reaction could also reflect uncertainty about Clover Health Investments' ability to maintain its competitive edge in the healthcare technology sector.
• Overall, the bearish trend in CLOV today could be a result of investors reevaluating the stock's valuation in light of the underwhelming financial performance in the recent quarter.

22.00.2026 - CLOV Stock was up 5.3%

• The rise in CLOV stock could be linked to the CEO's recent share sales, potentially indicating confidence in the company's future.
• Upbeat forecasts for profitability in 2026 and an annual increase in Medicare Advantage membership likely boosted investor confidence and led to the stock's upward movement.
• Despite a lack of profitability over the past year, the expectation of turning profitable this year and being deemed slightly undervalued by InvestingPro could have additionally stimulated investor interest in CLOV.

04.02.2026 - CLOV Stock was up 6.8%

• The company recorded remarkable 40% revenue growth in 2025, hitting $1.9 billion, and saw a 38% increase in its Medicare Advantage membership to 113,803. This strong financial performance likely influenced the stock's positive movement.
• Despite reporting a GAAP net loss in 2025, Clover Health achieved non-GAAP profitability, indicating effective operational practices and cost control measures.
• Clover Health's forecast of achieving GAAP net income profitability in 2026, coupled with revenue guidance ranging between $2.81 billion and $2.92 billion, presented a promising future for investors, driving bullish sentiment in the market.
• The company's strategic efforts, including enhancements to its Clover Assistant platform, expansion into new regions, and introduction of new products, showcase its dedication to growth and innovation, further enhancing investor trust in the stock.

06.10.2025 - CLOV Stock was down 7.2%

• Highlighting CLOV as a great choice for value investors due to recent strong momentum and reasonable prices might have attracted a lot of attention and buying interest.
• Break-even earnings for Q3 with negative surprises on earnings and positive surprises on revenue could have led to disappointment among investors, causing a sell-off and contributing to the bearish movement.
• Mixed signals from market participants, expecting momentum but receiving disappointing earnings clues, likely resulted in increased volatility and downward pressure on CLOV's stock price.

05.02.2026 - CLOV Stock was down 6.7%

• Today's downturn in Clover Health's stock (CLOV) can be linked to various factors:
• Strong revenue growth and an increase in Medicare Advantage membership were overshadowed by higher net losses and loss per share in the recent SEC 10-K filing, causing concerns among investors about the company's profitability.
• The company's aim to reach GAAP profitability by 2026, while making progress in non-GAAP profitability, has raised doubts about its financial targets.
• Efforts to expand product offerings and geographic reach, as outlined in the Form 10-K, may result in higher operating expenses and competitive challenges, prompting investor wariness.
• General market volatility in the healthcare sector or broader market conditions could have influenced market sentiment, leading some investors to approach Clover Health's stock with more caution.

01.07.2025 - CLOV Stock was down 5.9%

• Vicky Bruner's recent appointment as Vice President of Operations at Counterpart Health, a Clover Health subsidiary, suggests a strategic focus on expansion and enhancing operational efficiency.
• Despite this promising development, reactions from investors to the announcement may have been negative, potentially reflecting concerns about market sentiment or internal challenges faced by the company.
• The downward movement in CLOV's stock price could be attributed to broader market dynamics or selling pressure from traders capitalizing on previous price increases.

03.01.2026 - CLOV Stock was down 5.6%

• The bearish movement in CLOV stock today may be linked to the upcoming release of its fourth quarter and full year 2025 financial results. Investors seem cautious about the company's performance, resulting in a sell-off of shares ahead of the announcement. Market sentiment appears to be affected by concerns about Clover Health Investments, Corp.'s financial health and growth prospects.

06.07.2025 - CLOV Stock was down 22.9%

• Q2 earnings of Clover Health were in line with expectations, with a 34% revenue increase.
• Despite this, the stock declined as the company raised its Insurance BER guidance, sparking worries about margin pressures.
• The adverse outlook on insurance benefits expense ratio (BER) appears to have unsettled investors, resulting in the bearish trend in CLOV's stock price.

24.02.2026 - CLOV Stock was down 6.5%

• Today's bearish movement in Clover Health's stock (CLOV) could be linked to a series of insider selling activities by top executives, such as CEO Jamie L. Reynoso and General Counsel Karen Soares. This may be perceived by the market as a lack of confidence in the company's future performance, resulting in a negative investor sentiment.
• Executives' automatic withholding of shares to cover tax obligations from RSU vesting might suggest potential cash flow issues or personal financial commitments, which could further affect investor confidence in the stock.
• In summary, insider selling paired with tax-related share withholding likely contributed to the stock's bearish performance today, as investors react to signs of potential internal issues within the company.

23.08.2025 - CLOV Stock was up 7.9%

• CLOV is still considered undervalued, making it an appealing option for investors seeking promising stocks at reasonable prices.
• The bullish movement in CLOV is seen as an opportunity for investors looking for growth potential at an attractive price.
• This positive momentum reflects optimism among investors about Clover Health Investments' future prospects, leading to an increase in its stock price.
• The bullish movement in CLOV today could be linked to growing investor interest and favorable sentiment regarding the company's potential for growth.